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Chromosomal Methods in Population
Studies
by Mary K. Conner* and Niel Waldt
A brief description of chromosome aberrations and sister chromatid exchange (SCE) as
cytogenetic endpoints for evaluation of DNA damaging agents is presented. Problems associ-
ated with the use of cytogenetic assays as population monitors of radiation and chemical
exposures are discussed. Adequate cell sample size requirements and accurate assessment of
cummulative exposure effects with increasing age are stressed as important considerations for
reliable cost-benefit analysis of population studies involving low level exposures.
Examples of population studies using SCE as an indicator of specific chemical exposures are
cited, and factors contributing to variations in control baseline SCE levels are discussed.
Possible implications of population cytogenetic data on general public health are suggested.
Over the past 20 years, "conventional" chromo-
some aberration scoring in human peripheral blood
lymphocytes has been extensively used as a moni-
tor for radiation and chemical induced cytogenetic
toxicity. More recently, the introduction of band-
ing as well as sister chromatid exchange (SCE)
techniques has provided improved accuracy and
sensitivity in detection of DNA damaging agents.
At the microscopic level, cytogenetic effects
might be evident as aneuploidy (alterations in
chromosome numbers) or as aberrations (alter-
ations in chromosome morphology). At the molecu-
lar level, DNA damage may be characterized by
disruption of the integrity of the phosphoribose
backbone via direct single- or double-strand break-
age as typically resulting from radiation or, alter-
natively, by modification of the purine or pyrimi-
dine bases. Although the latter may produce labile
ribosyl bonds, DNA strand breakage does not
necessarily occur. Nevertheless, the various types
of DNA damage elicit repair processes whose
effects can become apparent as morphologically
altered chromosomes. The specific chromosomal
consequence of DNA damage is a function of the
type of DNA lesion, cell cycle time of induction of
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lesion, and its persistence (Fig. 1). DNA damage
initiated prior to DNA synthesis (S) may undergo
interchromosomal or intrachromosomal repair pro-
cesses and, following replication during S, produce
some chromosome-type aberrations as dicentrics,
acentrics, fragments, terminal or interstitial dele-
tions and breaks. Lesions induced during or per-
sisting until S may initiate chromatid-type aberra-
tions or increased SCE frequencies. Abnormal
morphological changes are evidence of lack of
repair or misrepair and, as such, are potentially
lethal. On the other hand, SCE is visible evidence
of successful repair, a condition expected to be
more compatible with events dependent upon cell
survival (e.g. mutagenesis and carcinogenesis).
Some fundamentally different cellular lesions or
processes may produce only aberrations or SCE
whereas other lesions may, under appropriate con-
ditions, induce both SCE and aberrations, with SCE
beingmore sensitive atloweragentconcentration (1).
The use of cytogenetic aberration scoring of
human blood cells has proved to be a sensitive
means of detecting biological changes produced by
radiation exposures of smaller magnitude than can
be detected by any other practical test system. It
has made possible studies involving short-term
external radiation exposure in vivo from a variety
of radiation sources, as well as parallel in vitro
studies. They have led to enhanced understanding
of basic radiobiological mechanisms as well as an
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FIGURE 1. Formation of chromosome type aberrations and SCE.
application of "biologic dosimetry" which has been
helpful in the management of accidental human
over-exposure patients, as well as those patients
receiving radionuclide therapy (2). When applied
in accidentally exposed radiation workers, Lloyd
et al. (3) found a lower limit ofdose estimate, with
500 cells analyzed, at 4 rad for 250 kV x-rays and
20 rad for cobalt-60 gamma radiation.
Only a relatively few investigations (4-9), pre-
sented in Table 1, have been concerned with the in
vivo response of human lymphocyte chromosomes
to lower levels ofexternal and/or internal radiation
exposure received on a continuous or intermittent
basis over long time periods despite the uncertain-
ties about and interest in such population expo-
sures. In general, these studies are difficult to
carry out because of the complexities of accurate
radiation exposure assessment at near background
environmental levels and the large number of cells
which must be evaluated in order to delineate any
significant departures from the normal range of
aberrations. Note the variations in the units used
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in quantitating the radiation exposures, which
make it difficult to summate the results. In gener-
al, the studies give some support to the idea that
radiation-induced chromosome aberrations can be
detected in populations in which sufficient num-
bers of cells are scored following radiation expo-
sure at levels beginning at low multiples of the
natural environmental radiation background.
Because of the large number of cells which
require scoring for detection of such low levels
effects, these changes are not detectable in indi-
viduals in whom the usual diagnostic level of cells
are scored. In our cytogenetics laboratory, the
preparation, scoring and analysis of 200 mitotic
cells takes approximately 14 man-hours. It is
therefore evident that a careful investigation of
the feasibility of cytogenetic screening for epide-
miologic investigations is necessary to make a
meaningful cost/benefit judgement about the pro-
posed research. A recent approach to the sample
size problem has been reported by Whorton and
colleagues (10). They studied the magnitude of
Environmental Health PerspectivesTable 1. In vivo cytogenetic studies of low-level radiated population.
Exposure source Dose groups Cells/dose groupa Reference
Environmental uranium and thorium 640 mr/yr C = 9,000 Barcinski et al. (14)
X = 13,242
Environmental radon-222 100-1200 mrad/in 6 mo. X = 30,598 Total Pohl-Ruhling et al. (5)
(? avg-3800/grp)
Environmental radon-222, drinking water 3-1200 nCi/L C = 4,520 Stenstrand et al. (6)
X = 1,000-2,000
Diagnostic urography 1-Ar C = 1,687 Kucerova et al. (7)
X = 1,627
Uranium workers < 100 to > 3,000 WLM C = 1,950 Brandon et al. (8)
X = 500-2,500
Nuclear shipyard workers 0.2-33 rem C = 1,500 Evans et al. (9)
X = 600-9,000
ac = control; X = exposed.
variation in the proportion of abnormal cells and
estimated the number of subjects and the number
of cells per subject needed to detect significant
increases of predetermined size over a control
value with a type I error of a = 0.05 and type II
errors of 1B = 0.20 or 0.10. They found that with a
= 0.05 and ,B = 0.10, about 20 subjects per group
and 200 cells per subject were needed to detect a
doubling over a control value for the variable
occurring at a rate of 0.02.
In another study of this problem, Redmond and
Gur (11) found that when the average radiation
exposure was set at 100 mrem and detection of a
statistically significant increase in dicentric fre-
quency was desired with a power of 0.75 (a =
0.05) assuming the relationship of age to chromo-
somal sensitivity for radiation-induced dicentric
formation is that described by Evans, et al. (9),
the following number of cells would have to be
scored: for a group at age 25, 10.6 x 106; for age
40, 2.5 x 106; for age 55, 1.1 x 106. With
background radiation-induced aberration frequen-
cies assumed to be dose-dependent, these require-
ments would change slightly to 9.7 x 106, 2.3 x
106 and 1.0 x 106. They also found that if 20,000
cells are to be scored for dicentric frequency and
the required power is 0.75 (a = 0.05), with a
dicentric background frequency of 2.5 ± 1 x 1074
per cell and age-related background radiation sen-
sitivity for radiation-induced dicentric formation
were present, then for a group at 25, with a
dicentric sensitivity of 1.6 ± 0.6 per 104 person-
rem, the lowest dose detectable would be 4.1 rem;
for age 40, with a dicentric formation sensitivity of
3.3 ± 0.6 per 104 person rem, the lowest detecta-
ble exposure would be 2.0 rem; and for age 55,
with a dicentric sensitivity of 5.0 ± 1.0 per 104
person-rem, the lowest detectable exposure would
be 1.3 rem. These observations are considered in
more detail in Dr. Redmond's presentation (11).
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It becomes apparent from the foregoing that the
use of cytogenetic techniques in epidemiologic
populations exposed to low doses of radiation over
long time periods must consider the sample size as
well as the effect of age on the end point. The
non-specific effect of age on increasing aneupolidy
was described in some detail by Court-Brown (12)
in his classic monograph on human population
cytogenetics. The relationship of increasing age to
cytogenetic radiosensitivity was reviewed by Evans,
et al. (9) recently. Both studies underscore the
need to control carefully forage effects in cytogenetic
population studies. In addition, in some low-dose
radiation studies, it is evident that cumulative
natural radiation background exposure and medi-
cal diagnostic radiation exposure, both age-related,
could be comparable in magnitude to the environ-
mental exposure being assessed. This possibility
must be taken into account in designing and
analyzing such population studies. Other consider-
ations include those of other agents which may
damage chromosomes such as chemicals and virus
infections.
The utilization of cytogenetic studies to detect
chemical damage to chromosomes is of relatively
recent origin. Initially, in vitro studies as well as
animal and exposure experiments served as the
basis for information about such cytogenetic dam-
age, as reviewed in detail by Shaw (13) in 1970.
More recently there have been attempts to extend
the utilization of this technique to human in vivo
exposed populations. Two series of studies sum-
marized by Forni et al. (14) and by Tough et al.
(15) are related to benzene-exposed workers in
Italy and Great Britain. While it was evident that
high exposures can produce chromosome damage,
no significant increases in the level of chromosome
abnormalities were found in some of the studies
involving workers exposed to low levels. An in-
crease in sensitivity to such damage with increas-
109ing age was also demonstrated by Tough et al.
(15). Other areas in which chemical effects have
been detected have involved cancer chemothera-
peutic agents, and consciousness altering drugs.
More recently occupational exposures have come
under study including those to vinyl chloride,
arsenic, lead and others. These are well summa-
rized in a recent review by Purchase (16).
Among the difficulties in interpreting the occu-
pational exposure studies, beyond those already
indicated as confounding factors in general popula-
tion studies, are the problems of quantitation of
duration of exposure and dose rate especially in
situations where there may be intermittent peaks
of brief over-exposure. Also the time after an
exposure which has elapsed before the chromo-
some study is performed has a great effect on the
dose-response relationship. In general, it appears
that population surveillance by chromosome aber-
ration scoring may be useful in chemically exposed
groups if sufficient quantitative exposure informa-
tion is available and large enough cell sample size
studies are performed. Such surveillance may be
facilitated by the automation ofaberration scoring,
which appears to be feasible in studies performed
at this institution (17).
The recent development of SCE techniques has
provided a more sensitive means for evaluation of
cytogenetic effects (18, 19) of a wide variety of
environmental, industrial and chemotherapeutic
agents. Sister chromatid differentiation of human
lymphocytes can be accomplished by incorporating
the thymidine analog, 5-bromo-2'-deoxyuridine
(BrdU) into chromosomal DNA for the duration of
two replication cycles. The chromosomes can sub-
sequently be stained differentially with fluorescent
or Giemsa stain (18). SCE are recognized as
reciprocal exchanges of differentially stained re-
gions between sister chromatids. The frequency of
such exchanges may increase following exposure
to various agents.
Because the use ofSCE as a population monitor-
ing method is relatively recent, many current
studies are concerned with establishment of con-
trol baselines and identification of factors contrib-
uting to variation in baselines. A summary of
baseline values as determined in normal control
subjects (> 10 individuals/study and approximately
20 cells/individual) in various laboratories (20-33) is
illustrated in Figure 2. Possible factors contribut-
ing to the observed variation between laboratories
might be due to: real differences in methods of
culturing and/or scoring cells or real differences in
the populations studied.
With respect to culturing methods, although
BrdU concentration in the culture media may play
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FIGURE 2. Variance ofcontrol SCE/cell among various labora-
tories.
some role in SCE induction (18), all studied cited
employed concentrations between 1 and 160 pM, a
range over which minimal effects on SCE variance
were reported (26). Nevertheless, establishment
ofstandard culturing and scoring procedures might
eventually reduce interlaboratory variations.
With regard to population differences many
factors have been evaluated. Variation within
control subjects, examined by comparison ofdupli-
cate cultures (23, 31) or ofrepeat cultures from the
same individual taken at 3 month intervals (31)
revealed no significant differences. Likewise, no
significant differences were apparent between sexes
(20, 31, 34) or with age from 0 to 85 yr (26, 31).
The most extensive evaluation of a control
population was reported by Morgan and Crossen
(31). In their study which included 1000 cells from
a total of 50 individuals, the population mean
SCE/cell was 7.9 ± 1.36. Within subjects the range
of SCE/cell was 1-21 with a mean variance of 2.9.
The distribution was judged normal by the non-
parametric Kolmogorov-Smirnov test. However, a
normal distribution is rejected ifthe data is tested
with the more powerful Shapiro-Wilkes test for
normality. Examination of the distribution reveals
an apparent skewing with possible outlying values.
The most extreme outlier (outside the 99.7%
range) reportedly was an individual who was
engaged as a worker in the rubber industry, an
occupation long associated with an increased inci-
dence of malignancy. For all other control individ-
uals, no indication was made concerning smoking
habits and/or general health, factors which are
critical to SCE baseline levels.
Significantly elevated SCE/cell means as well as
wider ranges of SCE/cell were observed in smok-
ers relative to nonsmokers (28, 32). Although the
number of cigarettes smoked per day and years
duration of smoking both contributed to elevated
SCE frequencies, the highest frequencies were
demonstrated by individuals who smoked more
than 10 cigarettes per day irrespective ofduration.
Increased SCE levels were also exhibited by
patients treated with chemotherapeutic agents
(35). Such increases are instructive, in that acute
Environmental Health Perspectivesdoses generally produce transient effects whereas
repeated administration of smaller lower doses
result in sustained increases, persisting for periods
of three months or more. These results reflect the
relatively long-lived nature of SCE-inducing le-
sions and lymphocyte life-span in vivo relative to
the expectedly much shorter plasmatic half-life of
active drug metabolites.
Significant increases in SCE frequencies (1.5-2
x baseline) have also been observed in lympho-
cytes of individuals with viral diseases such as
herpes simplex, cold/flu and hepatitis (27); arsenic-
induced skin cancers (20); and newly diagnosed
acute lymphoblastic leukemia (33).
In an epidemiologic occupational study (25),
SCE and chromosome aberrations were examined
in lymphocytes of workers exposed to various
organic solvents and of children (0-11 years) of
mothers who were pregnant at the time of expo-
sure. One group of technicians as well as the
exposed children had significantly higher mean
SCE/cell and chromosome aberrations relative to
corresponding nonexposed controls but no correla-
tion between SCE frequencies and aberrations
was apparent. The increased effects in children of
exposed mothers suggest that active agents might
be able to pass through the placenta and produce
lesions in lymphocytes which may remain latent
for years. However, contrary to other studies (26,
31) adult controls had higher mean SCE frequen-
cies that did control children. Detailed interviews
revealed that many control adults previously had
diagnostic x-rays, had taken different drugs for a
variety ofdisorders, and were smokers. Hence the
age difference might be due to continuous expo-
sures more common to the adult environment.
Two other studies indicate that SCE may be a
useful tool in occupation studies. In a recent report
regarding SCE levels in petroleum refinery work-
ers by Carrano et al. (36), approximately halfof22
workers had SCE frequencies in excess of two
standard errors above the "nonexposed" group
mean. While vinyl chloride workers exposed to
very low doses of 0.1 ppm for the relatively short
period oftwo years demonstrated normal SCE and
aberration levels (37) both were elevated in work-
ers exposed to 20 ppm and higher for 10 or more
years (38). Thus, induced chromosomal changes
apparently depends upon dose and length of expo-
sure.
It is clear from these population SCE studies
that there are many factors unrelated to specific
population exposures which might confound con-
trol as well as exposure results. Such factors must
be identified and as far as possible incorporated
into the experimental design. It might be expected
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that chronic low level effects may not produce
dramatic increases in population means, in which
case nonparametric statistics might be more ap-
propriate for comparison of control and exposed
groups. For example, careful examination of fre-
quency distributions may reveal a greater than
expected proportion of exposed individuals having
slightly elevated SCE frequencies.
Since not all chemical and physical agents (nota-
bly radiation) are effective SCE inducers, evidence
regarding specific activities should be sought by in
vitro laboratory testing or in vivo animal models
before employing the assay in large scale popula-
tion studies involving known agents.
Regardless of the specific chromosomal endpoint
employed, question arises as to interpretation of
population cytogenetic data. It must be kept in
mind that false negatives inherently result due to
limitations in the sensitivities of particular assays.
Although SCE is generally more sensitive than
chromosome aberrations, SCE are not induced by
all mutagens and carcinogens. On the other hand,
chromosome aberrations are induced by a wider
range of agents but represent rather gross, poten-
tially lethal genetic alterations and require higher
concentrations to produce significant effects. Fur-
thermore, the lymphocyte test system employed
for either assay is characterized by a Go cell
population which may be more resistant than other
more proliferative critical body tissues and, in
addition, possesses repair capability which may
diminish the apparent effect if prolonged time
intervenes before assay.
On the other hand, there is concern regarding
the implications of elevated chromosome aberra-
tions or SCE on an individual's or on the general
public's genetic health. Man-made relaxation of
genetic selection due to improved general medical
care over the past 50 years, coupled with increas-
ing environmental exposures, might be expected
to produce even greater increases in human ge-
netic diseases in future generations. Yet, the
extent to which mutation in lymphocytes can be
translated into germ cell effects and hence herita-
ble effects remain to be determined.
Perhaps of more immediate concern to present
populations are the facts that many carcinogenic
agents have been demonstrated to be mutagenic
(39) and many mutagens/carcinogens produce chro-
mosome aberrations or increase SCE in cultured
lymphocytes. However, although hypothetical re-
lationships exist between chromosome aberrations
and the origin of tumors (40), chromosomal effects
are not necessarily the causative factor in carcino-
genesis.
In spite ofthe facts that lymphocyte cytogenetic
111test systems detect only some of a wide spectrum
ofgenetic effects and the ultimate consequences to
individuals and populations cannot, at present, be
explicitly defined, such test systems are uniquely
accessible human test systems which provide evi-
dence of cytogenetic damage and under appropri-
ate exposure conditions, are an index for estima-
tion of human risk.
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